AAAAAA

   
Results: 1-14 |
Results: 14
Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations
Authors: Patel, L Charlton, SJ Chambers, JK Macphee, CH
Citation: L. Patel et al., Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations, CYTOKINE, 14(1), 2001, pp. 27-36
Tumor suppressor and anti-inflammatory actions of PPAR gamma agonists are mediated via upregulation of PTEN
Authors: Patel, L Pass, I Coxon, P Downes, CP Smith, SA Macphee, CH
Citation: L. Patel et al., Tumor suppressor and anti-inflammatory actions of PPAR gamma agonists are mediated via upregulation of PTEN, CURR BIOL, 11(10), 2001, pp. 764-768
The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A(2)
Authors: Boyd, HF Hammond, B Hickey, DMB Ife, RJ Leach, CA Lewis, VA Macphee, CH Milliner, KJ Pinto, IL Smith, SA Stansfield, IG Theobald, CJ Whittaker, CM
Citation: Hf. Boyd et al., The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A(2), BIOORG MED, 11(5), 2001, pp. 701-704
1-(Arylpiperazinylamidoalkyl)-pyrimidones: Orally active inhibitors of lipoprotein-associated phospholipase A(2)
Authors: Bloomer, JC Boyd, HF Hickey, DMB Ife, RJ Leach, CA Macphee, CH Milliner, KJ Pinto, IL Rawlings, DA Smith, SA Stansfield, IG Stanway, SJ Taylor, MA Theobald, CJ Whittaker, CM
Citation: Jc. Bloomer et al., 1-(Arylpiperazinylamidoalkyl)-pyrimidones: Orally active inhibitors of lipoprotein-associated phospholipase A(2), BIOORG MED, 11(14), 2001, pp. 1925-1929
The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages
Authors: Vosper, H Patel, L Graham, TL Khoudoli, GA Hill, A Macphee, CH Pinto, I Smith, SA Suckling, KE Wolf, CR Palmer, CNA
Citation: H. Vosper et al., The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages, J BIOL CHEM, 276(47), 2001, pp. 44258-44265
Inhibition of lipoprotein-associated phospholipase A(2) diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages
Authors: Carpenter, KLH Dennis, IF Challis, IR Osborn, DP Macphee, CH Leake, DS Arends, MJ Mitchinson, MJ
Citation: Klh. Carpenter et al., Inhibition of lipoprotein-associated phospholipase A(2) diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages, FEBS LETTER, 505(3), 2001, pp. 357-363
2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A(2)
Authors: Boyd, HF Flynn, ST Hickey, DMB Ife, RJ Jones, M Leach, CA Macphee, CH Milliner, KJ Rawlings, DA Slingsby, BP Smith, SA Stansfield, IG Tew, DG Theobald, CJ
Citation: Hf. Boyd et al., 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A(2), BIOORG MED, 10(4), 2000, pp. 395-398
N-1 substituted pyrimidin-4-ones: Novel, orally active inhibitors of lipoprotein-associated phospholipase A(2)
Authors: Boyd, HF Fell, SCM Flynn, ST Hickey, DMB Ife, RJ Leach, CA Macphee, CH Milliner, KJ Moores, KE Pinto, IL Porter, RA Rawlings, DA Smith, SA Stansfield, IG Tew, DG Theobald, CJ Whittaker, CM
Citation: Hf. Boyd et al., N-1 substituted pyrimidin-4-ones: Novel, orally active inhibitors of lipoprotein-associated phospholipase A(2), BIOORG MED, 10(22), 2000, pp. 2557-2561
Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease.
Authors: Packard, CJ O'Reilly, DSJ Caslake, MJ McMahon, AD Ford, I Cooney, J Macphee, CH Suckling, KE Krishna, M Wilkinson, FE Rumley, A Lowe, GDO
Citation: Cj. Packard et al., Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease., N ENG J MED, 343(16), 2000, pp. 1148-1155
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease
Authors: Caslake, MJ Packard, CJ Suckling, KE Holmes, SD Chamberlain, P Macphee, CH
Citation: Mj. Caslake et al., Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease, ATHEROSCLER, 150(2), 2000, pp. 413-419
The role of fractalkine in the recruitment of monocytes to the endothelium
Authors: Chapman, GA Moores, KE Gohil, J Berkhout, TA Patel, L Green, P Macphee, CH Stewart, BR
Citation: Ga. Chapman et al., The role of fractalkine in the recruitment of monocytes to the endothelium, EUR J PHARM, 392(3), 2000, pp. 189-195
Selective binding of the truncated form of the chemokine CK beta 8 (25-99)to CC chemokine receptor 1 (CCR1)
Authors: Berkhout, TA Gohil, J Gonzalez, P Nicols, CL Moores, KE Macphee, CH White, JR Groot, PHE
Citation: Ta. Berkhout et al., Selective binding of the truncated form of the chemokine CK beta 8 (25-99)to CC chemokine receptor 1 (CCR1), BIOCH PHARM, 59(5), 2000, pp. 591-596
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions
Authors: Hakkinen, T Luoma, JS Hiltunen, MO Macphee, CH Milliner, KJ Patel, L Rice, SQ Tew, DG Karkola, K Yla-Herttuala, S
Citation: T. Hakkinen et al., Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions, ART THROM V, 19(12), 1999, pp. 2909-2917
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor
Authors: Macphee, CH Moores, KE Boyd, HF Dhanak, D Ife, RJ Leach, CA Leake, DS Milliner, KJ Patterson, RA Suckling, KE Tew, DG Hickey, DMB
Citation: Ch. Macphee et al., Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor, BIOCHEM J, 338, 1999, pp. 479-487
Risultati: 1-14 |